LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,016,435 | -16.7% | 467,564 | +0.2% | 0.46% | -12.4% |
| Q2 2023 | $33,628,161 | +0.5% | 466,410 | +2.5% | 0.52% | -6.2% |
| Q1 2023 | $33,476,347 | +9.0% | 455,089 | +0.1% | 0.56% | +0.5% |
| Q4 2022 | $30,713,977 | -21.0% | 454,416 | +0.6% | 0.56% | -24.4% |
| Q3 2022 | $38,899,000 | -3.9% | 451,738 | -0.4% | 0.74% | -1.5% |
| Q2 2022 | $40,468,000 | -13.9% | 453,574 | +8.6% | 0.75% | +8.7% |
| Q1 2022 | $46,984,000 | -26.1% | 417,670 | +1.5% | 0.69% | -16.2% |
| Q4 2021 | $63,539,000 | +11.2% | 411,359 | +0.3% | 0.82% | +5.7% |
| Q3 2021 | $57,144,000 | +19.9% | 410,164 | +12.9% | 0.78% | +19.0% |
| Q2 2021 | $47,674,000 | -15.7% | 363,393 | -2.0% | 0.65% | -20.4% |
| Q1 2021 | $56,530,000 | -2.4% | 370,810 | -36.3% | 0.82% | -4.8% |
| Q4 2020 | $57,909,000 | +2.2% | 582,294 | -2.1% | 0.86% | -14.1% |
| Q3 2020 | $56,678,000 | -18.8% | 594,612 | -4.7% | 1.00% | -20.7% |
| Q2 2020 | $69,785,000 | +65.6% | 623,915 | +7.6% | 1.26% | +23.9% |
| Q1 2020 | $42,150,000 | -20.5% | 579,625 | +14.1% | 1.02% | +2.5% |
| Q4 2019 | $52,990,000 | +4.1% | 508,100 | -0.6% | 1.00% | -2.5% |
| Q3 2019 | $50,893,000 | +0.8% | 511,280 | +15.6% | 1.02% | +6.8% |
| Q2 2019 | $50,476,000 | -5.7% | 442,187 | +3.9% | 0.96% | -12.4% |
| Q1 2019 | $53,508,000 | -3.4% | 425,644 | +4.2% | 1.09% | -17.0% |
| Q4 2018 | $55,412,000 | -47.2% | 408,345 | +6.8% | 1.31% | -32.2% |
| Q3 2018 | $104,974,000 | +21.4% | 382,433 | -8.0% | 1.94% | +11.4% |
| Q2 2018 | $86,487,000 | +23.2% | 415,841 | -2.2% | 1.74% | +14.1% |
| Q1 2018 | $70,203,000 | +19.3% | 425,059 | -1.1% | 1.52% | +13.4% |
| Q4 2017 | $58,843,000 | -4.2% | 429,734 | -4.8% | 1.34% | -5.2% |
| Q3 2017 | $61,435,000 | +12.9% | 451,228 | +0.7% | 1.42% | +7.9% |
| Q2 2017 | $54,421,000 | +14.7% | 448,278 | -0.0% | 1.31% | +12.2% |
| Q1 2017 | $47,467,000 | +12.5% | 448,479 | +8.0% | 1.17% | -0.9% |
| Q4 2016 | $42,202,000 | +6.3% | 415,335 | +6.7% | 1.18% | -0.2% |
| Q3 2016 | $39,712,000 | -7.1% | 389,100 | +8.5% | 1.18% | -15.7% |
| Q2 2016 | $42,755,000 | +3.4% | 358,470 | -7.2% | 1.40% | -2.9% |
| Q1 2016 | $41,365,000 | -2.0% | 386,266 | -0.8% | 1.45% | -3.0% |
| Q4 2015 | $42,208,000 | +24.0% | 389,298 | -2.0% | 1.49% | +24.0% |
| Q3 2015 | $34,025,000 | -20.8% | 397,252 | -6.7% | 1.20% | -5.3% |
| Q2 2015 | $42,965,000 | +23.0% | 425,819 | -6.0% | 1.27% | +21.6% |
| Q1 2015 | $34,925,000 | +46.0% | 452,929 | +0.7% | 1.04% | +46.2% |
| Q4 2014 | $23,922,000 | +8.9% | 449,572 | -3.9% | 0.71% | +7.7% |
| Q3 2014 | $21,973,000 | +8.8% | 467,610 | +44.2% | 0.66% | +6.8% |
| Q2 2014 | $20,201,000 | +4.0% | 324,299 | +12.2% | 0.62% | +4.9% |
| Q1 2014 | $19,433,000 | +63.2% | 288,929 | +27.7% | 0.59% | +48.4% |
| Q4 2013 | $11,905,000 | +45.6% | 226,325 | +19.8% | 0.40% | +41.0% |
| Q3 2013 | $8,175,000 | – | 188,895 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |